Panasyuk G - Search Results

1

Intravenous administration of scAAV9-Hexb normalizes lifespan and prevents pathology in Sandhoff disease mice.

Niemir N, Rouvière L, Besse A, Vanier MT, Dmytrus J, Marais T, Astord S, Puech JP, Panasyuk G, Cooper JD, Barkats M, Caillaud C. Niemir N, et al. Among authors: panasyuk g. Hum Mol Genet. 2018 Mar 15;27(6):954-968. doi: 10.1093/hmg/ddy012. Hum Mol Genet. 2018. PMID: 29325092

2

Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease.

Nemazanyy I, Blaauw B, Paolini C, Caillaud C, Protasi F, Mueller A, Proikas-Cezanne T, Russell RC, Guan KL, Nishino I, Sandri M, Pende M, Panasyuk G. Nemazanyy I, et al. Among authors: panasyuk g. EMBO Mol Med. 2013 Jun;5(6):870-90. doi: 10.1002/emmm.201202057. Epub 2013 Apr 30. EMBO Mol Med. 2013. PMID: 23630012 Free PMC article.

3

Alteration of splicing factors' expression during liver disease progression: impact on hepatocellular carcinoma outcome.

Wang H, Lekbaby B, Fares N, Augustin J, Attout T, Schnuriger A, Cassard AM, Panasyuk G, Perlemuter G, Bieche I, Vacher S, Selves J, Péron JM, Bancel B, Merle P, Kremsdorf D, Hall J, Chemin I, Soussan P. Wang H, et al. Among authors: panasyuk g. Hepatol Int. 2019 Jul;13(4):454-467. doi: 10.1007/s12072-019-09950-7. Epub 2019 May 28. Hepatol Int. 2019. PMID: 31140152

4

Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism.

Nemazanyy I, Panasyuk G, Zhyvoloup A, Panayotou G, Gout IT, Filonenko V. Nemazanyy I, et al. Among authors: panasyuk g. FEBS Lett. 2004 Dec 17;578(3):357-62. doi: 10.1016/j.febslet.2004.10.091. FEBS Lett. 2004. PMID: 15589845 Free article.

5

Ribosomal protein S6 kinase 1 interacts with and is ubiquitinated by ubiquitin ligase ROC1.

Panasyuk G, Nemazanyy I, Filonenko V, Gout I. Panasyuk G, et al. Biochem Biophys Res Commun. 2008 May 2;369(2):339-43. doi: 10.1016/j.bbrc.2008.02.016. Epub 2008 Feb 13. Biochem Biophys Res Commun. 2008. PMID: 18279656

6

Generation and characterization of monoclonal antibodies to mTOR kinase.

Nemazanyy I, Breus O, Gout I, Filonenko V, Panasyuk G. Nemazanyy I, et al. Among authors: panasyuk g. Hybridoma (Larchmt). 2008 Oct;27(5):395-9. doi: 10.1089/hyb.2008.0035. Hybridoma (Larchmt). 2008. PMID: 18803507

7

mTORbeta splicing isoform promotes cell proliferation and tumorigenesis.

Panasyuk G, Nemazanyy I, Zhyvoloup A, Filonenko V, Davies D, Robson M, Pedley RB, Waterfield M, Gout I. Panasyuk G, et al. J Biol Chem. 2009 Nov 6;284(45):30807-14. doi: 10.1074/jbc.M109.056085. Epub 2009 Sep 2. J Biol Chem. 2009. PMID: 19726679 Free PMC article.

8

PPARγ contributes to PKM2 and HK2 expression in fatty liver.

Panasyuk G, Espeillac C, Chauvin C, Pradelli LA, Horie Y, Suzuki A, Annicotte JS, Fajas L, Foretz M, Verdeguer F, Pontoglio M, Ferré P, Scoazec JY, Birnbaum MJ, Ricci JE, Pende M. Panasyuk G, et al. Nat Commun. 2012 Feb 14;3:672. doi: 10.1038/ncomms1667. Nat Commun. 2012. PMID: 22334075 Free PMC article.

9

The role of the mTOR pathway during liver regeneration and tumorigenesis.

Panasyuk G, Patitucci C, Espeillac C, Pende M. Panasyuk G, et al. Ann Endocrinol (Paris). 2013 May;74(2):121-2. doi: 10.1016/j.ando.2013.03.003. Epub 2013 Apr 6. Ann Endocrinol (Paris). 2013. PMID: 23566619 Review.

10

Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression.

Nemazanyy I, Espeillac C, Pende M, Panasyuk G. Nemazanyy I, et al. Among authors: panasyuk g. Biochem Soc Trans. 2013 Aug;41(4):917-22. doi: 10.1042/BST20130034. Biochem Soc Trans. 2013. PMID: 23863156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters